Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain



Status:Recruiting
Conditions:Other Indications
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 75
Updated:4/21/2016
Start Date:November 2013
Contact:Mark Kendall, MD
Email:m-kendall@northwestern.edu
Phone:312-695-2528

Use our guide to learn which trials are right for you!

Phase 4 Study Comparing of Dexamethasone to Triamcinolone for Ultrasound-guided Trigeminal Nerve Block: A Randomized Controlled Trial.

Trigeminal neuralgia is a craniofacial pain syndrome that is typically characterized by
unilateral severe, recurrent, electrical pain in one or more distributions of the trigeminal
nerve. Current treatment strategies include oral medications as first line therapy with
surgical interventions reserved for those patients who are refractory to medications or
unable to tolerate medication side effects. Despite these current treatment options, many
patients continue to have symptoms. Ultrasound-guided trigeminal nerve block allows for fine
adjustment of the needle tip and direct observation of the medicine.

Local anesthetic and steroids have been successfully used for diagnostic and or therapeutic
nerve pain with great success. Steroids can be short or long acting in duration with varying
side effects. If there exists a difference in duration of action, using the longer acting
drug will provide a greater period of symptom relief for the patient and may allow the
patient to undergo fewer interventional procedures.


Inclusion Criteria:

- All patients presenting to the Northwestern Pain Center who are eligible and
scheduled to receive a ultrasound-guided trigeminal nerve block.

Exclusion Criteria:

- Exclusion is the same for patients who are not eligible for ultrasound guided nerve
blocks.
We found this trial at
1
site
Chicago, Illinois 60611
Principal Investigator: Antoun Nader, MD
?
mi
from
Chicago, IL
Click here to add this to my saved trials